Description
Peterson A, Largent EA, Lynch HF, Karlawish J, Sisti D. (2023). Journeying to Ixtlan: Ethics of Psychedelic Medicine and Research for Alzheimer’s Disease and Related Dementias. AJOB Neurosci, 14(2):107-123. 36476106.Should there be extra training or a new role that specializes in neuro medicine caregiving if caregivers are to become part of research involvement and treatment procedure so patients can feel appropriately supported and the healthcare team is more cohesive?How can we hold predatory pharmaceutical companies and investigators accountable when it comes to developing viable therapies for patients and their families who are desperate for relief? Should the government become more engaged and impose further regulations?How can public health leaders best address health equity concerns for marginalized communities, including barriers to accessing psychedelic medicine therapies and representation for future studies?chose one question to answer after reading artcile
